Despite limitations in specificity and the need for further in vivo validation, our study provides crucial insights into the interplay between HIF-1α signaling and CAR T cell function, serving as a foundational framework for the development of combination therapies aimed at optimizing CAR T cell performance in solid tumors like cervical cancer. Here, HIF1A is linked to cervical carcinoma.